These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14765384)

  • 41. Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.
    Blonski M; Pallud J; Gozé C; Mandonnet E; Rigau V; Bauchet L; Fabbro M; Beauchesne P; Baron MH; Fontaine D; Peruzzi P; Darlix A; Duffau H; Taillandier L
    J Neurooncol; 2013 Jun; 113(2):267-75. PubMed ID: 23479036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The Role of Chemotherapy in the Treatment of Low-grade Gliomas].
    Lakomý R; Kazda T; Poprach A; Pospíšil P; Jančálek R; Šlampa P
    Klin Onkol; 2017; 30(5):343-348. PubMed ID: 29031036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.
    Bower M; Newlands ES; Bleehen NM; Brada M; Begent RJ; Calvert H; Colquhoun I; Lewis P; Brampton MH
    Cancer Chemother Pharmacol; 1997; 40(6):484-8. PubMed ID: 9332462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
    Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma.
    Schönekaes K; Mücke R; Panke J; Rama B; Wagner W
    Tumori; 2002; 88(1):28-31. PubMed ID: 12004846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
    Germano IM; Emdad L; Qadeer ZA; Binello E; Uzzaman M
    Cancer Gene Ther; 2010 Sep; 17(9):664-74. PubMed ID: 20523363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of carbon ion radiotherapy to photon radiation alone or in combination with temozolomide in patients with high-grade gliomas: explorative hypothesis-generating retrospective analysis.
    Combs SE; Bruckner T; Mizoe JE; Kamada T; Tsujii H; Kieser M; Debus J
    Radiother Oncol; 2013 Jul; 108(1):132-5. PubMed ID: 23932193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should radiotherapy be standard therapy for brain tumors in the elderly? Cons.
    Chinot OL
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):68-71. PubMed ID: 14765390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas.
    Sherman JH; Moldovan K; Yeoh HK; Starke RM; Pouratian N; Shaffrey ME; Schiff D
    J Neurosurg; 2011 Jun; 114(6):1617-21. PubMed ID: 21235313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 53. Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
    Park CK; Lee SH; Han JH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
    BMC Cancer; 2009 Dec; 9():450. PubMed ID: 20017960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for glioma].
    Wang L; Tu Q; Zhou W; Zhou R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1106-10. PubMed ID: 22169729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.
    Harris MT; Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2001 Jul; 8(4):325-7. PubMed ID: 11437571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.
    Lashford LS; Thiesse P; Jouvet A; Jaspan T; Couanet D; Griffiths PD; Doz F; Ironside J; Robson K; Hobson R; Dugan M; Pearson AD; Vassal G; Frappaz D;
    J Clin Oncol; 2002 Dec; 20(24):4684-91. PubMed ID: 12488414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma.
    Duerinck J; Du Four S; Sander W; Van Binst AM; Everaert H; Michotte A; Hau P; Neyns B
    Anticancer Res; 2015 Oct; 35(10):5551-7. PubMed ID: 26408725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temozolomide as second-line chemotherapy for relapsed gliomas.
    Trent S; Kong A; Short SC; Traish D; Ashley S; Dowe A; Hines F; Brada M
    J Neurooncol; 2002 May; 57(3):247-51. PubMed ID: 12125988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temozolomide in low-grade gliomas: living longer and better.
    Rees J
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):359-60. PubMed ID: 25189160
    [No Abstract]   [Full Text] [Related]  

  • 60. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.